“

There is a thing called a Data Safety Monitoring Board, an independent body that is assigned to each clinical trial, we have no insight into the data until the DSMB says we can look at it. They can come back and say,' This is not a good vaccine.' They could come back before we even have 30,000 folks enrolled and say' We have enough. This looks great.'.